Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2

Details for Australian Patent Application No. 2006299016 (hide)

Owner Novartis AG

Inventors Walchli, Rudolf; Heng, Richard; Schlapbach, Achim; Velcicky, Juraj; Koch, Guido

Agent Davies Collison Cave

Pub. Number AU-A-2006299016

PCT Pub. Number WO2007/039285

Priority 0520164.5 04.10.05 GB

Filing date 4 October 2006

Wipo publication date 12 April 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039285 Priority application(s): WO2007/039285

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299017-Tetrahydro-pyrrolizinone compounds as LFA-I mediators

2006298995-Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists